FDA Inspection
GBA Pharma GmbHGBA Pharma GmbH – FDA Inspection, Jul 9, 2020
Record Details
This FDA Inspection record concerns GBA Pharma GmbH, with an inspection on July 9, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- GBA Pharma GmbH
- Inspection Date
- July 9, 2020
- Product Type
- Drugs
View Company Profile
ID · 1dca0385-bd54-42c0-9eff-436ed2af78e2
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1128748
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of GBA Pharma GmbH
2| Date | Classification | Office | Project area |
|---|---|---|---|
| January 29, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 30, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for GBA Pharma GmbH
- FDA Inspection 961236 - 2016-01-29
- FDA Inspection 605751 - 2009-07-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.